The Royal Osteoporosis Society and the APPG on Osteoporosis and Bone Health have published a new report exposing how a “postcode lottery” in NHS prescribing leaves over 1 million women without access to vital bone-strengthening treatments. This analysis calls for unified, system-wide policy reform to ensure equitable medication pathways for all.
Read the full report here.
ROS and APPG on Osteoporosis and Bone Health Inquiry Report on Access to Medicines
NHS England and NICE have worked together to produce new patient decision aids (also known as Decision Support Tools) last year,
by Sue Brown, CEO ARMA
